OMRON Healthcare Evolves the Blood Pressuring Experience with AI-powered AFib detection

Number one doctor and pharmacist-recommended blood pressure monitor brand introduces blood pressure monitors with OMRON Intellisense^™ AFib

HOFFMAN ESTATES, Ill., May 21, 2025 -- Heralding an evolution of the blood pressure monitoring experience, heart health leader OMRON Healthcare today introduced home blood pressure monitors with built-in AI-powered detection of atrial fibrillation. In a medical device first, OMRON blood pressure monitors which feature the company's new novel machine learning IntelliSense^™ AFib algorithm will automatically check for AFib during every blood pressure measurement and can provide early detection for a high stroke¹ and heart failure² risk.

"OMRON Healthcare is evolving the blood pressure monitoring experience by making AFib screening an integral part of every measurement. AFib is a serious condition that is widely undiagnosed. With Intellisense^™ AFib, we are working to help anyone who uses our blood pressure monitors detect this condition earlier so they can reduce the associated stroke, heart failure and dementia risks," said OMRON Healthcare U.S. Managing Director Alice Koehler.

OMRON blood pressure monitors with Intellisense^™ AFib are compatible with the OMRON Connect app and clinical accurate.

• OMRON Platinum BP5465: Featuring a backlit dual display and storage for 200 readings for two users (100 readings each user), OMRON Platinum is ranked by The New York Times Wirecutter as the overall "best blood pressure monitor for home use".
• OMRON 10 Series^® BP7465: This OMRON best-seller features a large, backlit display with TruRead technology, stores 200 readings for two users (100 readings each user), and is recommended by Consumer Reports for its accuracy and ease of use.
• OMRON 7 Series^® BP7360: With a large, easy-to-read display, this compact monitor stores 120 readings for two users (60 readings each user) and is rated by Health & Living as one of the Best Blood Pressure Monitors of 2025.
• OMRON Gold BP5360: A favorite for its sleek design and bright display, this monitor stores 160 readings (80 readings per user) and is highly rated as a "premium option" by BPM Reviews for its exceptional accuracy and ease-of-use.

"Our blood pressure monitors with Intellisense^™ AFib automatically screen for atrial fibrillation with every single measurement," said Koehler. "With this breakthrough AFib detection, OMRON is setting a new high standard for the blood pressure monitoring experience."

AFib is the most common type of heart arrythmia³. Left untreated, the condition increases risk of stroke, heart failure, myocardial infarction, chronic kidney disease, and dementia⁴.

AFib risk factors accelerate over age 40 and include high blood pressure, obesity, diabetes, smoking, heavy use of alcohol, and sleep apnea⁵.

Medical experts say AFib has become a health epidemic⁶. A study published in the September 2024 Journal of the American College of Cardiology⁷ found that AFib is three times more prevalent than previously estimated. The American Stroke Association estimates that millions of Americans with AFib are undiagnosed⁸ and many may not experience symptoms⁹.

OMRON IntelliSense^™ AFib incorporates over 300 mathematical indices into a machine learning algorithm that analyzes the Pressure Pulse Wave generated as the blood pressure monitor cuff inflates. A clinical study published in the October 2024 Heart Rhythm Journal¹⁰ found that OMRON blood pressure monitors with Intellisense^™ AFib can detect disturbances specific to AFib with remarkable accuracy.

The FDA granted OMRON Healthcare medical-device authorization for Intellisense^™ AFib via the agency's De Novo classification¹¹, a regulatory pathway for first-of-their-kind innovations.¹²

With the launch of blood pressure monitors with Intellisense^™ AFib, OMRON introduced an AFib education hub that explains the condition, its risk factors, and common symptoms. OMRON's AFib education hub provides details on how Intellisense^™ AFib works and how OMRON developed the innovation as part of its Going for Zero mission.

AFib education extends to the OMRON Connect app, which syncs with every Intellisense^™ AFib blood pressure monitor via Bluetooth to iOS^® and Android^® devices. OMRON Connect charts user readings by the day, week, month and year. The app analyzes a user's trends and habits, presents insights to explain data, and provides daily reminders and progress reports. With OMRON Connect, a user can send heart health readings to a doctor.

"Research shows ninety percent of heart attacks and strokes are preventable¹³. By evolving the blood pressure monitoring experience with Intellisense^™ AFib, OMRON is providing unprecedented at-home access to technologies that can make a world of difference in heart health," said Koehler.

About OMRON Healthcare, Inc.
OMRON Healthcare, Inc., is the world's leading manufacturer and distributor of personal heart health products and an innovator in technologies supporting respiratory and pain management care. With over 50 years of medical device category leadership, OMRON is passionate about empowering people to take charge of their health at home through precise technology. Its market-leading products include a full range of home blood pressure monitors, nebulizers and TENS devices. The company's mission is Going for Zero, the elimination of heart attacks and strokes. With more than 350 million devices sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals. OMRON Healthcare strives to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions. The company provides products and services in over 130 countries. For more information, visit OmronHealthcare.com.

¹ CDC AFib and Stroke https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html?CDC_AAref_Val=https://www.cdc.gov/heartdisease/atrial_fibrillation.htm
² AFib and Heart Failure https://www.hopkinsmedicine.org/health/conditions-and-diseases/atrial-fibrillation/afib-complications
³ CDC About Atrial Fibrillation https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html?CDC_AAref_Val=https://www.cdc.gov/heartdisease/atrial_fibrillation.htm
⁴ AFib and Dementia Risk https://pmc.ncbi.nlm.nih.gov/articles/PMC10568548/
⁵ NIH https://pmc.ncbi.nlm.nih.gov/articles/PMC8158444/
⁶ AHAIASA Journals https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.316340
⁷ JACC study https://medconnection.ucsfhealth.org/news/how-many-people-have-a-fib-three-times-more-than-we-thought
⁸ American Stroke Association https://scnow.com/news/health/many-people-have-atrial-fibrillation-but-may-not-know-it/article_bb910f20-cc44-11e9-8406-c39ac04db63b.html
⁹ Cleveland Clinic https://health.clevelandclinic.org/atrial-fibrillation-dispelling-6-myths
¹⁰ Heart Rhythm Journal, October 2024 https://www.heartrhythmjournal.com/article/S1547-5271(24)02520-7/fulltext
¹¹ FDA De Novo https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/de-novo-classification-request
¹² FDA De Novo AI First https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-device-uses-artificial-intelligence-help-detect-potential-signs-colon
¹³ Cleveland Clinic https://newsroom.clevelandclinic.org/2021/09/29/90-percent-of-heart-disease-is-preventable-through-healthier-diet-regular-exercise-and-not-smoking

This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.